Trafalgar International (GCAN) Net Shares Issued and Repurchased (2017 - 2019)
Trafalgar International (GCAN) posted Net Shares Issued and Repurchased of $769785.0 for Q1 2019, up 7597.85% on a QoQ basis from $10000.0 in Q1 2018, and up 7597.85% year-over-year from $10000.0 in Q1 2018.
Analysis
Trafalgar International (GCAN) Net Shares Issued and Repurchased (2017 - 2019) Analysis & Trends
Trafalgar International has reported Net Shares Issued and Repurchased for 3 years, with the latest figure at $769785.0 in Q1 2019.
- On a quarterly basis, Net Shares Issued and Repurchased rose 7597.85% year-over-year to $769785.0 in Q1 2019; TTM through Mar 2019 was $769785.0, a 7597.85% increase from a year earlier, with the FY2017 full-year figure at $10000.0, changed N/A from the prior year.
- Net Shares Issued and Repurchased was $769785.0 for Q1 2019 at Trafalgar International, up from $10000.0 in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $769785.0 in Q1 2019, with the low at $10000.0 in Q3 2017.
- Average Net Shares Issued and Repurchased over 3 years is $199946.2, with a median of $10000.0 recorded in 2017.
- The largest YoY upside for Net Shares Issued and Repurchased was 7597.85% in 2019 against a maximum downside of 7597.85% in 2019.
- Over 3 years, Net Shares Issued and Repurchased stood at $10000.0 in 2017, then changed by 0.0% to $10000.0 in 2018, then jumped by 7597.85% to $769785.0 in 2019.
- The last three Net Shares Issued and Repurchased figures came in at $769785.0 (Q1 2019), $10000.0 (Q1 2018), and $10000.0 (Q4 2017), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 769,785.00 |
| Mar 31, 2018 | 10,000.00 |
| Dec 31, 2017 | 10,000.00 |
| Sep 30, 2017 | 10,000.00 |